ArticleInfectious diseases of poverty2026
Rickettsia massiliae and its public health significance across Palearctic and Oriental regions: a scoping review.
Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundArthropod including ticks, fleas, and lice have been found to be infected with Rickettsia massiliae, a pathogenic member of spotted fever group, causing rickettsiosis. This comprehensive scoping review summarize the known facts about its transmission, diagnostic-methods, phylogenetic position, human-case-reports, preventive-measures, and distribution in Palearctic and Oriental regions.
methodsThree main steps were followed to compile this study: explanation of objective(s), identification of relevant literature, and retrieval of data determined by inclusion and exclusion criteria. Various databases, including Science Direct, Web of Science, PubMed, Scopus, Cochrane, and Google Scholar were screened for relevant literature. Our objectives were to collect data regarding transmission method(s) of R. massiliae, identification-assay(s), phylogenetic position, clinical-reports globally, and distribution via possible vectors & host animals surviving in Palearctic and Oriental regions. Descriptive analysis has been conducted to plot the frequency graphs of reported numbers in different countries and hosts.
resultsFindings presented that R. massiliae have been found across Palearctic and Oriental regions in 5 tick genera (Rhipicephalus, Hyalomma, Haemaphysalis, Ixodes, Amblyomma, and Dermacentor), 1 of louse (Haematopinus), 1 of sheep ked (Melophagus), and 1 of flea (Archaeopsylla), although their role as a vector(s) is still unknown. Dogs, sheep, cattle, and goats were recorded as epidemiologically important host animals for infected arthropods in 30, 23, 17, and 16 different studies, highlighting their role in its possible transmission. Additionally, Rh. sanguineus sensu lato (s.l) and Rh. turanicus were reported to infest the aforementioned animals, which is also being recognized as potential vector for its transmission. Highest number of R. massiliae reports (10) from different animals and vectors were recorded in China. Italy was recorded with highest (3) clinical cases of humans to-date. Moreover, transmission methods like transovarial via Rh. turanicus and horizontal/artificial-feeding via Rh. sanguineus s.l. and various diagnostic methods for R. massiliae have been documented.
conclusionsR. massiliae has been widely documented throughout Palearctic and Oriental regions, with human cases reported in about six countries. Rh. sanguineus and Rh. turanicus stands out the potential vectors, while further investigation into the implications of diverse range of arthropods in epidemiology of this bacterium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.